-

Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X Gyroscopic Radiosurgery

Access to Brain Tumor Treatment Gets Major Boost in Rocky Mountain Region

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc. today announced that Denver-based Neurosurgery One became the first provider in the Rocky Mountain region to treat patients using the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP-X is the latest advancement in completely non-invasive brain tumor treatment and aims to set new standards in patient safety, comfort, convenience, and treatment accuracy. Neurosurgery One doctors are now performing stereotactic radiosurgery (SRS) using ZAP-X in an outpatient facility in the south Denver metro area of Littleton, Colorado.

The first patient, a male in his 50s who has lived in Colorado for forty-five years, was treated for an acoustic neuroma (also known as vestibular schwannoma), a benign tumor of the nervous system. Acoustic neuromas are known to cause hearing loss, in addition to pain, dizziness and balance problems.

“As an electrical contractor with a passion for kiteboarding, windsurfing, skiing and foiling, I live a very active lifestyle, so maintaining my quality of life is extremely important,” said Bill Lawson, the first ZAP-X patient treated at Neurosurgery One. “I am excited to be the first ZAP-X patient in Colorado. Knowing that I was treated by the most modern, cutting-edge technology with an excellent team behind the treatment is very rewarding.”

“Our neurosurgeons have treated patients for decades with stereotactic radiosurgery as a precise non-surgical option for cranial conditions, including brain tumors, meningiomas, trigeminal neuralgia, and vestibular schwannomas,” said Dr. J. Adair Prall, MD, FAANS, senior partner and CEO of Neurosurgery One in Denver. “Having the ZAP-X system now allows us to treat our patients with the latest SRS technology and provide world-class care in a convenient and easy-to-access location.”

Stereotactic Radiosurgery is a well-established procedure to non-invasively treat many primary and metastatic brain tumors with high-intensity radiation, and often provides equivalent or superior clinical outcomes to surgery. When compared to historical whole brain radiotherapy (WBRT), which often requires many weeks of radiation treatment, SRS minimizes healthy brain tissue exposure and has demonstrated improved preservation of patient cognitive function.

“Unlike multi-purpose, full-body radiotherapy systems, ZAP-X was purpose-built without compromise for treating the brain with SRS,” said Dr. Darlene Bugoci, radiation oncologist in Littleton. “This focused approach supports the clinical objective of reducing radiation exposure to healthy brain tissue and mitigating the risks of potential neuro-cognitive deficit and related complications.”

Being the first and only “vault-free” radiation delivery technology, ZAP-X also eliminates the long-standing practice of prolonged patient isolation in a two-to-three-million-pound concrete bunker during treatment. This pioneering approach also now allows the clinical team, and in some instances, family members to be adjacent to the patient during treatment, with the goal of creating a more comfortable and confident patient experience.

Learn more at Zap Surgical and follow us on LinkedIn and Twitter. Detailed system videos can be found on Zap Surgical’s YouTube page.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60.

About Neurosurgery One

At Neurosurgery One, our entire team is committed to helping you achieve a higher quality of life. Our highly trained and experienced medical teams develop customized treatment plans using the most-advanced procedures and technology. We offer many types of minimally invasive spine and brain surgery to help you recover faster with less pain. Learn more at www.NeurosurgeryOne.com.

Contacts

Mark Arnold, ZAP Surgical Systems, Inc.
Senior Vice President, Marketing
+1 650 492 7797, ext. 101
Email: info@zapsurgical.com

Michele Conklin, Neurosurgery One
+1 720.232.7211
Email: michele@clementinewords.com
(Available to coordinate interviews with Dr. Prall)

ZAP Surgical Systems, Inc.


Release Versions

Contacts

Mark Arnold, ZAP Surgical Systems, Inc.
Senior Vice President, Marketing
+1 650 492 7797, ext. 101
Email: info@zapsurgical.com

Michele Conklin, Neurosurgery One
+1 720.232.7211
Email: michele@clementinewords.com
(Available to coordinate interviews with Dr. Prall)

Social Media Profiles
More News From ZAP Surgical Systems, Inc.

ZAP-X Gyroscopic Radiosurgery Platform to Debut in Taiwan at Kaohsiung Show Chwan Memorial Hospital

KAOHSIUNG CITY, Taiwan--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the first vault-free ZAP-X® Gyroscopic Radiosurgery® platform in Taiwan will be installed at Kaohsiung Show Chwan Memorial Hospital (KSCH). This marks a significant milestone in the region’s adoption of cutting-edge stereotactic radiosurgery (SRS) technology. Installation is set to begin in Q4 2025, with patient treatments expected to commence in Q1 20...

ZAP Surgical Unveils the ZAP-Axon® Radiosurgery Planning System

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the ZAP-Axon® Radiosurgery Planning System*, an entirely new software platform dedicated to the company’s ZAP-X® Gyroscopic Radiosurgery® system. Designed to simplify, accelerate, and enhance treatment planning, Axon aims to set new benchmarks in world-class radiosurgery brain tumor treatments. Axon is currently pending FDA 510(k) clearance and is expected to b...

ZAP Surgical Secures $78M in Series E Funding Led by Baheal Medical

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the successful closing of a $78 million Series E funding round led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new financing will advance the commercialization of the Company’s pioneering ZAP-X® Gyroscopic Radiosurgery® platform. Stereotactic radiosurgery (SRS) is a well-established procedure for the non-invasive treat...
Back to Newsroom